Author:
Jimenez Camilo,Rohren Eric,Habra Mouhammed Amir,Rich Thereasa,Jimenez Paola,Ayala-Ramirez Montserrat,Baudin Eric
Publisher
Springer Science and Business Media LLC
Reference99 articles.
1. • Ayala-Ramirez M, Feng L, Johnson MM, Ejaz S, Habra MA, Rich T, et al. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: Primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab. 2011;96(3):717–25. To date, this is the largest published study on clinical predictors of malignancy.
2. Goldstein RE, O'Neill Jr JA, Holcomb 3rd GW, Morgan 3rd WM, Neblett 3rd WW, Oates JA, et al. Clinical experience over 48 years with pheochromocytoma. Ann Surg. 1999;229(6):755–64. discussion 764–756.
3. Adjalle R, Plouin PF, Pacak K, Lehnert H. Treatment of malignant pheochromocytoma. Horm Metab Res. 2009;41(9):687–96.
4. Patel M, Santos P, Jong I, Nandurkar D, McKay J. Malignant pheochromocytoma metastasis to the breast shown on I-123 MIBG scan. Clin Nucl Med. 2010;35(10):816–7.
5. Srinivasan R, Kini U, Babu MK, Jayaseelan E, Pradeep R. Malignant pheochromocytoma with cutaneous metastases presenting with hemolytic anemia and pyrexia of unknown origin. J Assoc Physicians India. 2002;50(5):731–3.
Cited by
149 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献